Cited by 14Statistical Methods and InferenceRadiomics and Machine Learning in Medical ImagingProstate Cancer Treatment and Research

Cost-effective survival prediction for patients with advanced prostate cancer using clinical trial and real-world hospital registry datasets

Open access
Murtojärvi, Mika, Halkola, Anni S., Airola, Antti, Laajala, Teemu D., Mirtti, Tuomas, Aittokallio, Tero, Pahikkala, Tapio·2020·International Journal of Medical Informatics

Abstract

INTRODUCTION: Predictive survival modeling offers systematic tools for clinical decision-making and individualized tailoring of treatment strategies to improve patient outcomes while reducing overall healthcare costs. In 2015, a number of machine learning and statistical models were benchmarked in the DREAM 9.5 Prostate Cancer Challenge, based on open clinical trial data for metastatic castration resistant prostate cancer (mCRPC). However, applying these models into clinical practice poses a practical challenge due to the inclusion of a large number of model variables, some of which are not routinely monitored or are expensive to measure. OBJECTIVES: To develop cost-specified variable selection algorithms for constructing cost-effective prognostic models of overall survival that still preserve sufficient model performance for clinical decision making. METHODS: Penalized Cox regression models were used for the survival prediction. For the variable selection, we implemented two algorithms: (i) LASSO regularization approach; and (ii) a greedy cost-specified variable selection algorithm. The models were compared in three cohorts of mCRPC patients from randomized clinical trials (RCT), as well as in a real-world cohort (RWC) of advanced prostate cancer patients treated at the Turku University Hospital. Hospital laboratory expenses were utilized as a reference for computing the costs of introducing new variables into the models. RESULTS: Compared to measuring the full set of clinical variables, economic costs could be reduced by half without a significant loss of model performance. The greedy algorithm outperformed the LASSO-based variable selection with the lowest tested budgets. The overall top performance was higher with the LASSO algorithm. CONCLUSION: The cost-specified variable selection offers significant budget optimization capability for the real-world survival prediction without compromising the predictive power of the model.

Integrity signals

Registry

Crossref · 10.1016/j.ijmedinf.2019.104014

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 35 · Cited by 14

Authors
Murtojärvi, M., Halkola, A. S., Airola, A., Laajala, T. D., Mirtti, T., Aittokallio, T., & Pahikkala, T.
Affiliations
  • University of Turku (FI)
  • University of Helsinki (FI)
Corresponding author
Murtojärvi, Mika
Venue
International Journal of Medical Informatics
Publisher
Elsevier BV
Published
2020-01
Volume
133
Pages
104014
ISSN
1386-5056 (ISSN-L)
OpenAlex
W2988487920
Cited by
14
References
35
Citations by year
2026: 2 · 2025: 1 · 2023: 2 · 2022: 1 · 2021: 6 · 2020: 2
FWCI
1.76
Type
journal article
Language
en
Open access
Locations
  • International Journal of Medical Informatics (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UTUPub (University of Turku) (submittedVersion)
  • UTUPub (University of Turku) (submittedVersion, cc-by-nc-nd)
  • Työväentutkimus Vuosikirja (submittedVersion)
Funders
  • Suomen Kulttuurirahasto
  • Syöpäjärjestöt
  • Suomen Lääketieteen Säätiö
  • Sigrid Juséliuksen Säätiö
  • Helsingin ja Uudenmaan Sairaanhoitopiiri
  • Turun Yliopisto
  • Academy of Finland
Topics
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods and Inference
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
Keywords
metastatic castration-resistant prostate cancer, overall survival prediction, feature selection, LASSO regularization, hospital laboratory costs, clinical trial data, healthcare cost reduction
MeSH terms
Clinical Decision-Making, Aged, Aged, 80 and over, Algorithms, Cost-Benefit Analysis, Hospitals, Humans, Male, Prognosis, Prostatic Neoplasms, Registries

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review